Covidien Aims To Breathe Life Into Respiratory Biz With Ventilation Pipeline
This article was originally published in The Gray Sheet
Executive Summary
Covidien plans to reinvigorate its respiratory business by targeting higher-growth market segments, such as devices to combat ventilator-associated pneumonia, the company said during its Sept. 10 investor day in New York